Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SMAD1 antisense RNA 1 (SMAD1-AS1) is a long noncoding RNA transcript located antisense to the SMAD1 gene locus in the human genome[3]. It belongs to the class of natural antisense transcripts (NATs) that may regulate gene expression at the RNA level—either by forming duplexes with sense transcripts, modulating stability, influencing splicing, or indirectly affecting transcription of neighboring genes[4]. While the biological and pathological roles of some antisense lncRNAs are well-characterized, specific functional roles for SMAD1-AS1 remain incompletely defined and require further experimental validation. No drugs are known to target SMAD1-AS1 directly, and it is not currently considered a canonical therapeutic target. Its precise impact on SMAD1 function or disease remains unclear in current literature[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SMAD1 antisense RNA 1 (SMAD1-AS1).